BlackRock Institutional Trust’s AbbVie ABBV Stock Holding History

BlackRock Institutional Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.72B	Buy	43,460,085 +596,256	+1%	+$36.4M	0.4%	39
2016 Q3	$2.7B	Buy	42,863,829 +528,048	+1%	+$34.2M	0.42%	42
2016 Q2	$2.62B	Buy	42,335,781 +370,153	+0.9%	+$22.6M	0.43%	44
2016 Q1	$2.4B	Sell	41,965,628 -521,690	-1%	-$29.1M	0.4%	46
2015 Q4	$2.52B	Sell	42,487,318 -1,066,651	-2%	-$61.4M	0.42%	43
2015 Q3	$2.37B	Sell	43,553,969 -2,294,421	-5%	-$149M	0.41%	41
2015 Q2	$3.08B	Buy	45,848,390 +500,308	+1%	+$32.7M	0.5%	34
2015 Q1	$2.65B	Buy	45,348,082 +3,264,776	+8%	+$197M	0.41%	44
2014 Q4	$2.75B	Buy	42,083,306 +247,732	+0.6%	+$15.6M	0.44%	39
2014 Q3	$2.42B	Sell	41,835,574 -1,692,903	-4%	-$94M	0.41%	42
2014 Q2	$2.46B	Sell	43,528,477 -336,217	-0.8%	-$17.6M	0.41%	39
2014 Q1	$2.25B	Buy	43,864,694 +928,161	+2%	+$46.9M	0.39%	44
2013 Q4	$2.27B	Sell	42,936,533 -890,792	-2%	-$43.8M	0.4%	43
2013 Q3	$1.96B	Sell	43,827,325 -1,367,937	-3%	-$60.6M	0.38%	43
2013 Q2	$1.87B	Buy	+45,195,262	New	+$1.98B	0.38%	45

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

BlackRock Institutional Trust's ABBV Position: Q4 2016 in Review

BlackRock Institutional Trust increased its AbbVie (ABBV) stake by 1.4% in Q4 2016, buying an estimated $36.4M and bringing the position to 43,460,085 shares worth $2.72B. The position accounts for 0.4% of the portfolio, ranked #39.

BlackRock Institutional Trust first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.08B in Q2 2015. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

BlackRock Institutional Trust held 43,460,085 shares of AbbVie worth $2.72B as of Q4 2016.
BlackRock Institutional Trust bought 596,256 AbbVie shares in Q4 2016, an estimated $36.4M.
AbbVie made up 0.4% of BlackRock Institutional Trust's portfolio in Q4 2016, its #39 holding.
BlackRock Institutional Trust first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's AbbVie position peaked at $3.08B in Q2 2015.
1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.